Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerrit Jan Schuurhuis

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2016
MRD in AML: does it already guide therapy decision-making?Gert Ossenkoppele, Gerrit Jan Schuurhuis
Expert Review of Hematology|November 19, 2010
Minimal residual disease in acute myeloid leukemia: already predicting a safe haven?Gerrit Jan Schuurhuis, Gert Ossenkoppele
Blood|March 23, 2013
MRD in AML: time for redefinition of CR?Gert Ossenkoppele, Gerrit Jan Schuurhuis
Best Practice & Research. Clinical Haematology|December 3, 2014
MRD in AML: it is time to change the definition of remissionGert J Ossenkoppele, Gerrit Jan Schuurhuis
International Journal of Hematology|March 31, 2017
Leukemic stem cells: identification and clinical applicationDiana Hanekamp, Jacqueline Cloos, Gerrit Jan Schuurhuis
Current Protocols in Cytometry|November 26, 2019
Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid LeukemiaWendelien Zeijlemaker, Angele Kelder, Jacqueline Cloos, et al.
Best Practice & Research. Clinical Haematology|June 18, 2019
Can we incorporate MRD assessment into clinical practice in AML?Gert Ossenkoppele, Gerrit Jan Schuurhuis, Arjan van de Loosdrecht, et al.
British Journal of Haematology|March 10, 2011
Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasmsGert J Ossenkoppele, Arjan A van de Loosdrecht, Gerrit Jan Schuurhuis
Current Hematologic Malignancy Reports|April 29, 2010
New approaches for the detection of minimal residual disease in acute myeloid leukemiaAnna van Rhenen, Bijan Moshaver, Gert J Ossenkoppele, et al.
Expert Review of Hematology|September 23, 2014
Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment designRolf Wouters, David Cucchi, Gertjan J L Kaspers, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Hematology. American Society of Hematology. Education Program|December 4, 2016
MRD in AML: does it already guide therapy decision-making?Gert Ossenkoppele, Gerrit Jan Schuurhuis
Expert Review of Hematology|November 19, 2010
Minimal residual disease in acute myeloid leukemia: already predicting a safe haven?Gerrit Jan Schuurhuis, Gert Ossenkoppele
Blood|March 23, 2013
MRD in AML: time for redefinition of CR?Gert Ossenkoppele, Gerrit Jan Schuurhuis
Best Practice & Research. Clinical Haematology|December 3, 2014
MRD in AML: it is time to change the definition of remissionGert J Ossenkoppele, Gerrit Jan Schuurhuis
International Journal of Hematology|March 31, 2017
Leukemic stem cells: identification and clinical applicationDiana Hanekamp, Jacqueline Cloos, Gerrit Jan Schuurhuis
Current Protocols in Cytometry|November 26, 2019
Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid LeukemiaWendelien Zeijlemaker, Angele Kelder, Jacqueline Cloos, et al.
Best Practice & Research. Clinical Haematology|June 18, 2019
Can we incorporate MRD assessment into clinical practice in AML?Gert Ossenkoppele, Gerrit Jan Schuurhuis, Arjan van de Loosdrecht, et al.
British Journal of Haematology|March 10, 2011
Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasmsGert J Ossenkoppele, Arjan A van de Loosdrecht, Gerrit Jan Schuurhuis
Current Hematologic Malignancy Reports|April 29, 2010
New approaches for the detection of minimal residual disease in acute myeloid leukemiaAnna van Rhenen, Bijan Moshaver, Gert J Ossenkoppele, et al.
Expert Review of Hematology|September 23, 2014
Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment designRolf Wouters, David Cucchi, Gertjan J L Kaspers, et al.
Pageof 5